These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6980440)

  • 21. [Betalactam antibiotics combined with bectalactamases inhibitors. Amoxicillin-sulbactam].
    Barcelona L; Marín M; Stamboulian D
    Medicina (B Aires); 2008; 68(1):65-74. PubMed ID: 18416324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasmids and antibiotic resistance in gram-negative bacteria.
    Farrar WE
    J S C Med Assoc; 1980 Feb; 76(2):71-6. PubMed ID: 6987459
    [No Abstract]   [Full Text] [Related]  

  • 23. Resistance to aminoglycoside antibiotics of gram-negative bacilli isolated in Canadian hospitals.
    Duncan IB; Cheung EY; Haldane EV; Jackson FL; McNaughton RD; Morisset RA; Noble MA; Rennie RP; Ronald AR; Smith JA
    Can Med Assoc J; 1981 May; 124(9):1165-7. PubMed ID: 7237336
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Coding method in identifying gram-negative bacteria (I)].
    Polovoĭ AM
    Voen Med Zh; 1982 Sep; (9):33-7. PubMed ID: 6758336
    [No Abstract]   [Full Text] [Related]  

  • 25. Monobactams--monocyclic beta-lactam antibiotics produced by bacteria.
    Sykes RB; Bonner DP; Bush K; Georgopapadakou NH; Wells JS
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():1-16. PubMed ID: 6976959
    [No Abstract]   [Full Text] [Related]  

  • 26. Ertapenem: no effect on aerobic gram-negative susceptibilities to imipenem.
    Goff DA; Mangino JE
    J Infect; 2008 Aug; 57(2):123-7. PubMed ID: 18644627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Broad-spectrum beta-lactamases in Gram-negative bacteria].
    Sundsfjord A; Simonsen GS; Haldorsen B; Lundblad EW; Samuelsen O
    Tidsskr Nor Laegeforen; 2008 Dec; 128(23):2741-5. PubMed ID: 19079424
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Aztreonam. A small-spectrum antibiotic in gram-negative infections].
    Sander J
    Tidsskr Nor Laegeforen; 1991 Aug; 111(18):2277-8. PubMed ID: 1896987
    [No Abstract]   [Full Text] [Related]  

  • 29. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: beta-lactams in peril!
    Thomson JM; Bonomo RA
    Curr Opin Microbiol; 2005 Oct; 8(5):518-24. PubMed ID: 16126451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aztreonam: a new concept in beta-lactam antibiotics.
    Fernandes PB; Bonner DP; Sykes RB
    Compr Ther; 1983 May; 9(5):21-6. PubMed ID: 6682744
    [No Abstract]   [Full Text] [Related]  

  • 31. [Sensitivity of bacteria to chemotherapeutic agents (Zurich 1980). Part II. Bacteria isolated from outpatients].
    Kayser FH; Wüst J; Munzinger J
    Schweiz Med Wochenschr; 1982 Mar; 112(12):417-8. PubMed ID: 7071563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antibiotic sensitivity of obligate anaerobic bacteria].
    Poliak MS; Miasnikova LG
    Antibiotiki; 1982 May; 27(5):391-6. PubMed ID: 7049072
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum beta-lactamases.
    Shah AA; Hasan F; Ahmed S; Hameed A
    Res Microbiol; 2004; 155(6):409-21. PubMed ID: 15249058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antibiotics: action and resistance in gram-negative bacteria.
    Siu LK
    J Microbiol Immunol Infect; 2002 Mar; 35(1):1-11. PubMed ID: 11950113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Resistance to newer beta-lactams and related ESBL types in gram-negative nosocomial isolates in Turkish hospitals: results of the multicentre HITIT study].
    Gür D; Gülay Z; Akan OA; Aktaş Z; Kayacan CB; Cakici O; Eraç B; Gültekin M; Oğünç D; Söyletir G; Unal N; Uysal S
    Mikrobiyol Bul; 2008 Oct; 42(4):537-44. PubMed ID: 19149074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tigecycline: in-vitro performance as a predictor of clinical efficacy.
    Hawkey P; Finch R
    Clin Microbiol Infect; 2007 Apr; 13(4):354-62. PubMed ID: 17359318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissemination of nim-class genes, encoding nitroimidazole resistance, among different species of Gram-negative anaerobic bacteria isolated in Athens, Greece.
    Katsandri A; Avlamis A; Pantazatou A; Houhoula DP; Papaparaskevas J
    J Antimicrob Chemother; 2006 Sep; 58(3):705-6. PubMed ID: 16867996
    [No Abstract]   [Full Text] [Related]  

  • 38. Bacterial resistance mechanisms to beta-lactam antibiotics: assessment of management strategies.
    Dudley M
    Pharmacotherapy; 1995; 15(1 Pt 2):9S-14S. PubMed ID: 7753692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Antibiograms in ambulatory medical practice. Results with a group of gram-negative bacilli strains isolated by uroculture].
    Rozen P; Blajovan L; Dumitrescu LC
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1982; 27(3):199-210. PubMed ID: 7156696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SQ 26,776: in-vitro antibacterial activity and susceptibility to beta-lactamases.
    Phillips I; King A; Shannon K; Warren C
    J Antimicrob Chemother; 1981 Dec; 8 Suppl E():103-10. PubMed ID: 6976960
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.